• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    The Next Steps for Recovery and Rehab

    Scratching the Surface: A Roundtable on Coatings and Treatments

    Influencers on the Orthopedic Implant Manufacturing Market

    Innovation Iteration: Latest Advancements in Design & Prototyping

    Robot Recharge: Orthopedic Surgical Robotics Update
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Researchers Discover Novel Patching Material for Bone Defects

    Boston Centerless Opens Second Manufacturing Plant in Indiana

    Researchers Develop Patient-Specific 3D-Printed Smart Metamaterial Implants

    Global Sports Medicine Market to Approach $9B by 2028

    ODT's Most-Read Stories This Week—June 25
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    A Call to Action in Orthopedics: We Need to Personalize Every Single Hip and Knee Surgery

    ODT's Most-Read Stories This Week—June 25

    Isto Biologics Rolls Out Influx Fibrant

    Bioventus Amends CartiHeal Acquisition Structure

    Medtronic's LigaPASS 2.0 OK'ed for Ligament Augmentation in Spine Surgery
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    A Call to Action in Orthopedics: We Need to Personalize Every Single Hip and Knee Surgery

    Giving Knee Replacement Surgery a Much-Needed Update

    It’s All About the Data for Supply Chain and Inventory Management

    Minimizing Risks in Minimally Invasive Surgery

    Giving Athletes Their Lives Back with Better Knee Braces
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Tiodize

    Braxton Manufacturing

    Life Science Outsourcing Inc.

    Modern Plastics

    AV&R
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Columns

    Nitinol and FDA Guidance: Key Insights to Consider for Medical Devices

    Manufacturers using at least one nitinol device component must consider recent FDA guidance and protect end users from nickel-ion release.

    Nitinol and FDA Guidance: Key Insights to Consider for Medical Devices
    Figure 1: Corrosion testing paradigm flowchart
    Dr. Sherry Parker and Dr. Kimberly Ehman, WuXi AppTec Medical Device Testing05.17.21
    With its unique properties, nitinol is a popular material choice for medical devices but there are critical factors to keep in mind when considering potential risk and patient safety. More than 50 percent of nitinol is nickel, and nickel-ion release can lead to sensitization as well as systemic and local tissue effects. Manufacturers using at least one nitinol device component must consider recent U.S. Food and Drug Administration (FDA) guidance and protect end users from nickel-ion release.

    The FDA's “Technical Considerations for Non-Clinical Assessment of Medical Devices Containing Nitinol” covers guidance in four primary areas: mechanical testing, corrosion, biocompatibility, and labeling. Identifying and resolving potential biocompatibility concerns when corrosion is a possibility can be challenging, especially with devices that were not previously required to meet this regulatory expectation. Standard chemical characterization testing cannot predict the potential toxicological effects of nickel ion release over time, which leaves a gap to fill during safety evaluation.

    The Need for Nickel Ion Release Evaluations
    The way the medical device industry evaluates products from a patient safety standpoint is constantly evolving. Nitinol differs from other metals that manufacturers might use in medical devices like stainless steel or titanium. Specifically, nitinol has shape memory qualities and flexibility that are difficult to replace with alternative materials.

    The FDA’s guidance states, "Given the complex thermomechanical behavior of nitinol, there are unique considerations when assessing the safety and performance of nitinol devices."

    Required methods that would traditionally identify material risks such as chemical characterization and toxicological risk assessments (TRAs) cannot fully capture its nickel release concerns. Therein, the need for alternative approaches remains. When a device has the potential for corrosion, and particularly when it is an implantable device, regulators are looking to see expanded testing to evaluate the risks of adverse health effects.

    Nickel ion release is the primary concern with the presence of nitinol. Surface processing can have a significant impact on corrosion and nickel ion release. If a device does not have an established surface finish, manufacturers may need to perform an in-vitro nickel ion release study. Understanding the potential for nickel ion release may help the manufacturer optimize the manufacturing process if it decides to take a different approach with the surface finish of nitinol.

    Key Call Outs in FDA Guidance Updates
    Nitinol has long been a red flag for regulators evaluating cardiovascular devices, and with the increased interest in using minimally invasive procedures, nitinol applications have expanded.

    Transcatheter heart valves, orthodontic devices, stents, and orthopedic fracture fixation (e.g., plates, screws, staples) are all examples of medical devices the FDA will be watching for evidence that nickel release is not a concern.

    Manufacturers should evaluate any device containing nitinol that has either prolonged contact or long-term patient exposure under the latest guidance. Limited contact devices are considered at lower risk for nickel ion release and may not require the same testing. But any limited contact devices with an electrically active component, dissimilar metal couple or degradable metal/polymer components may also need to address nitinol risks under this guidance. In short, the test requirements for nickel ion release now include many more types of devices beyond just cardiovascular devices.

    Manufacturers with nitinol-containing devices seeking advice on meeting regulatory expectations should consult the recent guidance. As shown by Figure 1, the addition of a corrosion testing flowchart acts as a valuable resource to understand expectations. This chart demonstrates where to look for corrosion testing acceptance criteria (ASTM F2129) and the steps to follow if testing does not meet criteria, or meets criteria but does not have an established surface finish. If additional testing is needed, manufacturers should use in-vitro nickel ion release methods to support the risk assessment.

    Considerations for Prolonged and Long-Term Contacting Devices
    Manufacturers can avoid costly delays by recognizing the pros and cons of each material choice before beginning safety testing. This foresight is crucial for prolonged or long-term contacting devices due to the heightened expectations. Even then, the slightest of changes to the manufacturing process can impact surface properties. These cases and any other corrosion possibility can affect a device's biocompatibility and the necessary testing requirements. If companies make manufacturing changes, consider additional testing and communicate goals with testing partners at the onset.

    When laboratory testing partners have experience with nitinol and the testing needed, they can help avoid repeat studies and other potential delays. The investments in both biocompatibility and chemical characterization testing for implantable devices are substantial, and the last thing anyone wants is lack of communication to be the detrimental downfall.

    The Limitations of Biocompatibility Testing Methods
    Systemic toxicity is a concern for leachable metal ions, and while the FDA guidance document recommends an acceptable level for a TRA, this does not address sensitization concerns. The route and duration of exposure are key inputs to systemic toxicity; however, this endpoint can be addressed in a TRA because there is an established acceptable daily exposure.

    Alternatively, sensitization is not easy to predict and functions in a manner much like an allergic reaction. The immune response leading to sensitization is variable between animal models and humans, and across the human population as a whole. Consequently, the use of different testing systems is not always predictive of the human response. Due to variability, there is no known lower limit on the amount of nickel that can elicit a sensitization response in some patients or be applied in the TRA.

    The risk assessment of the chemical characterization and nickel ion release studies can address potential systemic toxicity to nickel. Still, regulators continue to view in-vivo models as the gold standard for addressing possible sensitization. Additionally, the guidance recommends potential risk mitigation through labeling, particularly for prolonged and long-term contacting devices.

    Manufacturers who are still unsure how testing recommendations apply to their device can get feedback from regulators using a Q-sub process outlined in the guidance updates for direct consultation. The guidance also provides additional resources to help companies get started on this process.

    Emerging Approaches to Protect Patient Safety
    Protecting patient safety has taken new forms in recent years with a shift to more customized testing that addresses device-specific risks rather than a checklist approach. This guidance speaks to a clear theme of regulators looking into the potential material risks of each device. This trend is also evident in standards like ISO 10993-18:2020, which guides medical device biological safety testing through more detailed chemical characterization to support the evaluation of toxicological risks.

    Additionally, a wide range of devices is now included under the standard, representing even more device categories and patient exposures than before. In particular, prolonged exposure and long-term contacting devices are the most affected by this guidance. For many companies, this might be a learning curve, but fortunately, they have resources including previous knowledge from the cardiovascular category and support from partners such as testing laboratories.

    Before embarking on upcoming medical device safety testing, manufacturers should vet any potential impact from nitinol components on their test plan. Understanding the risks associated with each material choice is key, and customizing testing to fit this helps satisfy regulator questions. 


    Dr. Parker has more than 20 years of toxicology and medical device experience, and is an expert in biological evaluation of medical devices and combination products. She received her Ph.D. in molecular and cellular pharmacology from the University of Miami. In her current position as WuXi AppTec’s senior director of Regulatory Toxicology, Dr. Parker provides manufacturers with guidance on global regulatory and technical requirements and testing program design. In May 2019, Dr. Parker was appointed to a three-year term as co-chair of the Biological Evaluation (AAMI/BE) Committee, the U.S. mirror committee for ISO 10993. In addition, she is currently an internationally recognized ISO expert and a U.S. delegate for TC 194, the technical committee for ISO 10993, and is the past president of the Medical Device and Combination Products Specialty Section of the Society of Toxicology.

    Dr. Ehman serves as a Technical and Regulatory director at WuXi AppTec Medical Device Testing, with a focus on medical device and combination products. Dr. Ehman has more than 18 years of toxicology and medical device experience, with expertise in toxicological risk assessments for medical devices, food and beverage products, and electronic nicotine delivery systems. In her current position, she provides medical device manufacturers with technical and regulatory support for biocompatibility test programs and conducts quantitative toxicological risk assessments to support product safety and risk management decisions. 
    Loading, Please Wait..

    Trending
    • Boston Centerless Opens Second Manufacturing Plant In Indiana
    • 3Spine Inc. Receives IDE Approval For U.S. Pivotal Clinical Trial
    • Red Point Medical 3D’s Bunion Surgery System Cleared By FDA
    • Isto Biologics Rolls Out Influx Fibrant
    • Bioventus Launches DUROLANE In The U.S.
    Breaking News
    • Researchers Discover Novel Patching Material for Bone Defects
    • Boston Centerless Opens Second Manufacturing Plant in Indiana
    • Researchers Develop Patient-Specific 3D-Printed Smart Metamaterial Implants
    • Global Sports Medicine Market to Approach $9B by 2028
    • ODT's Most-Read Stories This Week—June 25
    View Breaking News >
    CURRENT ISSUE

    May/June 2022

    • The Next Steps for Recovery and Rehab
    • Scratching the Surface: A Roundtable on Coatings and Treatments
    • Influencers on the Orthopedic Implant Manufacturing Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    CoQ10 and Royal Jelly Supplementation May Improve High Intensity Exercise
    Shiitake Mushroom Extract Appears Helpful in HPV Infections
    Fi & Hi Europe Returns with Over 20,000 Global Attendees Expected
    Coatings World

    Latest Breaking News From Coatings World

    H.M. Royal Becomes Exclusive OCSiAl Distributor
    American Colors to Expand Sandusky, Ohio Facility
    Vaughn O’Dea Named Director of Epoxytec
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cepheid, BioGX Partner to Create GeneXpert Monkeypox Test
    Siemens' Varian Gains FDA IDE Nod for FAST-02 Trial
    Acutus Medical Launches AcQCross Line Extension
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
    Pfizer, BioNTech Adapt COVID Vax Against Omicron
    CoreRx Expands Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Top 5 Beauty Tech Trends at Perfect Corp.'s Global Forum
    John Frieda Supports the LGBTQIA+ Community
    Athena Club Launches in Canada
    Happi

    Latest Breaking News From Happi

    Fencing Champion Bebe Vio Grandis Named Spokeswoman of L’Oréal Paris
    Past Henkel Exec Christian Chopra Named President of Scotch Porter
    Color Street Celebrates Foster, Adoption Awareness with Limited-Edition Print
    Ink World

    Latest Breaking News From Ink World

    Dr. Tammo Boinowitz to Join Management Board of ALTANA AG
    Flint Offset Packaging Solutions Announces Price Increases for Sheetfed Inks
    Weekly Recap: INX’s VC Fund, Screen Industry and Ball Top This Week’s News
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Harveer Sahni recognized with Global Achievement Award
    Color-Logic partners with Taktiful 
    ALTANA announces Management Board change
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Fibertex Personal Care Awarded EcoVadis Awards for Sustainability
    Yanpai Orders Batt Forming Equipment for Needlepunch Line
    Weekly Recap: SWM and Neenah Introduce Mativ Inc., Avgol honored for Biotransformation Technology & More
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Researchers Discover Novel Patching Material for Bone Defects
    Boston Centerless Opens Second Manufacturing Plant in Indiana
    Researchers Develop Patient-Specific 3D-Printed Smart Metamaterial Implants
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv-Powered CVS Spoken Rx Wins NFC Forum 2022 Innovation Award
    LG Display Announces Winners of This Year’s OLEDs GO! Competition
    Weekly Recap: eMagin, Applied Materials, and Schott Top This Week’s Stories

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login